|
Market Cap (5-Jun) $3,159,507 (1,963rd) |
Close (30-Jun) $0.028 |
Volume (30-Jun) 42,322 |
Shortsold (5-Apr) 9,554 (0.01%) (569th) |
|
52w High $0.020 |
52w Low $0.005 |
P/E - |
EPS -0.01 |
ANR released this announcement to the ASX on 6 August 2021, 9:02. The announcement is marked as price sensitive, and is 4 page(s) in length and 204.94kb in size.
You can view all announcements from ANR and see how they appear on a price chart on the announcements page.
At the date of this announcement, ANR was 0.003% short sold according to ASIC data. It was ranked the 598th most shorted stock on the ASX. It is now ranked as the 569th most shorted stock on the ASX with 0.006% of total shares short sold as of the latest reported data (05 April 2024).
| Other Recent Announcements from ANR | |
|---|---|
| Anatara Update on GaRP Irritable Bowel Syndrome Trial | 6 June 2023, 8:19 |
| Anatara Investor Presentation | 8 May 2023, 10:44 |
| Registered Office Change | 20 April 2023, 11:51 |
| Successful Piglet Study | 6 August 2021, 9:02 |
| Monthly Activities/Appendix 4C Cash Flow Report | 28 July 2021, 10:29 |
| Anatara Chair Transition | 26 July 2021, 10:14 |
| Anatara progressing towards first human clinical studies | 31 May 2021, 8:41 |
You must be logged in to post a reply.
Anatara Lifesciences 